Production (Stage)
CorMedix Inc.
CRMD
$12.36
$0.100.82%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 39.08M | 31.21M | 11.46M | 806.10K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 39.08M | 31.21M | 11.46M | 806.10K | -- |
| Cost of Revenue | 1.60M | 1.18M | 686.60K | 509.80K | 818.50K |
| Gross Profit | 37.48M | 30.03M | 10.77M | 296.30K | -818.50K |
| SG&A Expenses | 14.17M | 15.37M | 13.33M | 14.95M | 15.05M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.96M | 18.27M | 14.74M | 16.11M | 16.70M |
| Operating Income | 20.13M | 12.94M | -3.29M | -15.30M | -16.70M |
| Income Before Tax | 20.64M | 13.46M | -2.78M | -14.15M | -15.86M |
| Income Tax Expenses | -- | 0.00 | -- | -- | -1.39M |
| Earnings from Continuing Operations | 20.64M | 13.46M | -2.78M | -14.15M | -14.47M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.64M | 13.46M | -2.78M | -14.15M | -14.47M |
| EBIT | 20.13M | 12.94M | -3.29M | -15.30M | -16.70M |
| EBITDA | 20.29M | 13.07M | -3.21M | -15.22M | -16.68M |
| EPS Basic | 0.32 | 0.22 | -0.05 | -0.25 | -0.25 |
| Normalized Basic EPS | 0.20 | 0.14 | -0.03 | -0.15 | -0.17 |
| EPS Diluted | 0.30 | 0.22 | -0.05 | -0.25 | -0.25 |
| Normalized Diluted EPS | 0.19 | 0.14 | -0.03 | -0.15 | -0.17 |
| Average Basic Shares Outstanding | 65.24M | 61.51M | 58.83M | 57.62M | 57.50M |
| Average Diluted Shares Outstanding | 68.98M | 61.51M | 58.83M | 57.62M | 57.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |